• diffuse cutaneous systemic sclerosis treatment market size openPR.com Thu, 01 May 2025 13:03:00 GMT
• Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp BioSpace Tue, 29 Apr 2025 12:20:06 GMT
• will pfizer's non-covid drugs drive sales again this earnings season? TradingView Fri, 25 Apr 2025 11:06:00 GMT
• prediction: 1 biotech stock that could surpass pfizer by 2030 24/7 Wall St. Thu, 24 Apr 2025 17:14:07 GMT
• global hodgkin's lymphoma market trends: forecast and key openPR.com Thu, 24 Apr 2025 07:24:00 GMT
• strategic leadership boost: protara gains 20-year oncology expert as cmo ahead of key trial data Stock Titan Tue, 15 Apr 2025 20:13:00 GMT
• pfizer stock falls to new 52-week low: should you buy the dip? Yahoo Finance Thu, 10 Apr 2025 13:44:00 GMT
• ottimo pharma strengthens board with appointment of roger dansey, m.d. to its board of directors The Manila Times Thu, 10 Apr 2025 07:00:00 GMT
• diffuse large b-cell lymphoma pipeline 2025: fda approvals, therapies, clinical trials, and latest insights unveiled by delveinsig... Barchart.com Tue, 25 Mar 2025 14:54:00 GMT
• triple negative breast neoplasms treatment market size in 7mm openPR Wed, 19 Mar 2025 06:53:00 GMT
• Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success Stock Titan Thu, 13 Mar 2025 07:00:00 GMT
• Spotlight On: Bourla defends cost of Seagen deal as Pfizer looks to long-game in ADCs FirstWord Pharma Wed, 05 Mar 2025 08:00:00 GMT
• pfizer wants in on summit’s goal to beat keytruda via adc combos Endpoints News Mon, 24 Feb 2025 12:18:00 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid HPBL Tue, 18 Feb 2025 13:39:57 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Tue, 18 Feb 2025 02:56:24 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid HPBL Mon, 17 Feb 2025 20:43:07 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Mon, 17 Feb 2025 08:20:03 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Sun, 16 Feb 2025 21:33:42 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid – market HPBL Sun, 16 Feb 2025 12:56:51 GMT
• pfizer reports strong quarterly profits with growth from non-covid products – market HPBL Sun, 16 Feb 2025 04:39:51 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Sat, 15 Feb 2025 20:18:43 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid – market HPBL Sat, 15 Feb 2025 19:56:50 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Fri, 14 Feb 2025 22:25:26 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid – market HPBL Fri, 14 Feb 2025 22:04:01 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Fri, 14 Feb 2025 21:49:12 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Thu, 13 Feb 2025 22:50:15 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Thu, 13 Feb 2025 19:16:12 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Wed, 12 Feb 2025 22:25:03 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid – market HPBL Wed, 12 Feb 2025 14:07:11 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Wed, 12 Feb 2025 13:04:39 GMT
• pfizer q4 earnings beat expectations, but stock falls amid patent concerns and integration risks HPBL Wed, 12 Feb 2025 11:53:17 GMT
• Pfizer gets DLBCL nod for Adcetris, but will the ADC see much late-line use? FirstWord Pharma Wed, 12 Feb 2025 08:00:00 GMT
• pfizer in talks to acquire cancer drugmaker seagen BW Healthcare World Tue, 11 Feb 2025 03:01:38 GMT
• pfizer 2025 outlook: investor scrutiny, cost-cutting, and q4 growth News & Insights Mon, 10 Feb 2025 08:00:00 GMT
• Pfizer builds out oncology team with appointment of Novartis vet Jeff Legos Fierce Biotech Thu, 06 Feb 2025 08:00:00 GMT
• pfizer reports 2024 revenues 7% higher at $63.6 billion Indian Pharma Post Wed, 05 Feb 2025 05:31:23 GMT
• pfizer q4 earnings beat expectations, but stock falls amid patent concerns and integration risks HPBL Tue, 04 Feb 2025 17:19:12 GMT
• pfizer beats q4 estimates with 22% revenue growth and strong earnings, powered by key products and seagen acquisition – market HPBL Tue, 04 Feb 2025 17:14:11 GMT
• pfizer posts strong q4 2024 earnings but stock drops amid concerns over patent expirations and integration risks HPBL Tue, 04 Feb 2025 17:13:24 GMT
• pfizer reports strong quarterly profits with growth from non-covid products – market HPBL Tue, 04 Feb 2025 17:00:32 GMT
• pfizer q4 earnings surge past expectations: strong sales boosted by seagen and paxlovid – market HPBL Tue, 04 Feb 2025 16:58:54 GMT
• pfizer takes $1.2b hit after assessing prospects of seagen adcs Fierce Biotech Tue, 04 Feb 2025 13:46:29 GMT
• Pfizer axes B7-H4 ADC, triggering $1B impairment charge as blockbuster vision evaporates Fierce Biotech Tue, 04 Feb 2025 08:00:00 GMT
• Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook Yahoo Finance Tue, 04 Feb 2025 08:00:00 GMT
• Pfizer's COVID-19 portfolio outperforms as cost cuts pay off FirstWord Pharma Tue, 04 Feb 2025 08:00:00 GMT
• pfizer says it has at least $10b available for deals in 2025, with a focus on pipeline Endpoints News Tue, 04 Feb 2025 08:00:00 GMT
• pfizer eyes deals up to $15b, with ‘fruitful’ china discussions ongoing BioSpace Tue, 04 Feb 2025 08:00:00 GMT
• pfizer shows profit growth from cost cuts and steadier covid sales Reuters Tue, 04 Feb 2025 08:00:00 GMT
• pfizer drug acquired in $11b buyout confirms benefit in colon cancer BioPharma Dive Mon, 03 Feb 2025 08:00:00 GMT
• hodgkin lymphoma market promising growth anticipated by 2031 | merck & co., inc., bristol myers squibb, seagen inc. openPR Wed, 29 Jan 2025 09:04:00 GMT
• as trump and rfk jr. move to upend drug making, seattle biotech bets on science The Seattle Times Wed, 29 Jan 2025 08:00:00 GMT
• seattle inno - terrapower's massive raise i a loss for seagen The Business Journals Fri, 17 Jan 2025 03:30:43 GMT
• seattle inno - a chat with mariza hardin i former seagen ceo not facing charges The Business Journals Wed, 01 Jan 2025 18:01:28 GMT
• prediction: this $43 billion bet will help pfizer stock take off in 2025. The Motley Fool Sun, 29 Dec 2024 08:00:00 GMT
• Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic Fierce Biotech Thu, 19 Dec 2024 08:00:00 GMT
• ottimo raises $140m to ready pd1/vegfr2 antibody for clinic Fierce Biotech Thu, 19 Dec 2024 08:00:00 GMT
• ottimo raises $140mn in pursuit of ‘$100bn market’ for new cancer drugs Financial Times Thu, 19 Dec 2024 05:02:10 GMT
• ottimo raises $140mn in pursuit of ‘$100bn market’ for new cancer drugs Financial Times Wed, 18 Dec 2024 08:00:00 GMT
• pfizer to close seagen manufacturing plant in seattle area following $43b acquisition MSN Tue, 17 Dec 2024 02:30:58 GMT
• remegen reports phase iii success for disitamab vedotin The Pharma Letter Mon, 16 Dec 2024 16:21:07 GMT
• pieris pharmaceuticals announces $5 million milestone from seagen for initiation of phase 1 trial of cd228 x 4-1bb bispecific mole... Marketscreener.com Sun, 15 Dec 2024 12:54:14 GMT
• pfizer to close seagen manufacturing plant in seattle area following $43b acquisition MSN Mon, 09 Dec 2024 12:29:54 GMT
• next generation antibody therapeutics market growth in future openPR Fri, 06 Dec 2024 11:23:00 GMT
• cramer's lightning round: merus is ‘very speculative' NBC Philadelphia Wed, 04 Dec 2024 23:59:06 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Wed, 04 Dec 2024 08:00:00 GMT
• gastroesophageal adenocarcinoma market to show remarkable growth trends from 2024 to 2034, delveinsight reports | askgene pharma, ... Barchart Tue, 03 Dec 2024 15:24:59 GMT
• pfizer to close seagen manufacturing plant in seattle area following $43b acquisition MSN Fri, 29 Nov 2024 15:37:07 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Mon, 25 Nov 2024 08:00:00 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Thu, 21 Nov 2024 13:30:00 GMT
• pfizer appoints chris boshoff as chief scientific officer and president, research & development Indian Pharma Post Thu, 21 Nov 2024 05:42:52 GMT
• Pfizer promotes oncology chief to lead R&D as activist Starboard circles Financial Times Wed, 20 Nov 2024 08:00:00 GMT
• pfizer taps oncology head boshoff as dolsten’s chief scientific officer successor Endpoints News Wed, 20 Nov 2024 08:00:00 GMT
• pfizer picks boshoff to head r&d, a smooth transition in an uncertain time Citeline News & Insights Wed, 20 Nov 2024 08:00:00 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Thu, 14 Nov 2024 17:18:00 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Wed, 13 Nov 2024 20:41:00 GMT
• cramer's lightning round: american water works is ‘consistent' NBC Philadelphia Wed, 13 Nov 2024 08:00:00 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Thu, 07 Nov 2024 18:34:00 GMT
• Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost? Yahoo Finance Mon, 04 Nov 2024 08:00:00 GMT
• is pfizer stock a sell after covid products drive surprise upside? Investor's Business Daily Thu, 31 Oct 2024 15:11:15 GMT
• petri dish: epilepsy drug to enter clinic; new cfo for agtech firm The Business Journals Thu, 31 Oct 2024 07:00:00 GMT
• pfizer lifts outlook in first earnings report since activist investor standoff FirstWord Pharma Tue, 29 Oct 2024 19:37:12 GMT
• pfizer braces for activist battle with forecast increase The Edge Malaysia Tue, 29 Oct 2024 14:08:33 GMT
• pfizer raises profit forecast after beating third-quarter estimates KFGO Tue, 29 Oct 2024 11:42:44 GMT
• pfizer bumps up revenue outlook by $1.5b in paxlovid rebound amid criticism from activist investor starboard Fierce Pharma Tue, 29 Oct 2024 07:00:00 GMT
• pfizer rides paxlovid sales growth to better-than-expected third quarter AP News Tue, 29 Oct 2024 07:00:00 GMT
• pfizer ceo defends performance after starboard activist criticism Financial Times Tue, 29 Oct 2024 07:00:00 GMT
• After Pfizer deal, former Seagen CEO returns to lead oncology startup BioPharma Dive Mon, 28 Oct 2024 07:00:00 GMT
• Novartis, Seagen veteran David Epstein is back, leading a new cancer startup statnews.com Mon, 28 Oct 2024 07:00:00 GMT
• Seagen’s Ex-CEO Starts Company to Develop Drug Tackling Wide Range of Cancers Bloomberg.com Mon, 28 Oct 2024 07:00:00 GMT
• Former Seagen CEO David Epstein to lead new biotech with VEGF bifunctional antibody Endpoints News Mon, 28 Oct 2024 07:00:00 GMT
• Ottimo Pharma launches under former Seagen chief exec | Biotechnology | The Pharmaletter The Pharma Letter Mon, 28 Oct 2024 07:00:00 GMT
• Ottimo Pharma Emerges With An Ex-Seagen CEO And A PD1/VEGF Bispecific Contender insights.citeline.com Mon, 28 Oct 2024 07:00:00 GMT
• pharmalittle: we're reading about a merck drug-label controversy, astellas pulling an application, and more STAT Mon, 28 Oct 2024 07:00:00 GMT
• ottimo steps out of the shadows with 'exquisitely designed' pd-1/vegfr2 play FirstWord Pharma Mon, 28 Oct 2024 04:14:36 GMT
• pfizer to ‘catch our breath’ on deals after $43 billion purchase MSN Sun, 27 Oct 2024 19:33:49 GMT
• pfizer's 2030 vision bolstered by seagen deal, analyst cuts price target amid conservative 2024 forecast MSN Sat, 26 Oct 2024 15:27:29 GMT
• metastatic her2-positive breast cancer market expected to experience major growth by 2034, according to delveinsight | ambrx, zyme... The Globe and Mail Fri, 25 Oct 2024 07:00:00 GMT
• as activist starboard engages constructively, here’s a potent prescription for pfizer’s future success under dr. bourla’s watch Fortune Thu, 24 Oct 2024 07:00:00 GMT
• pfizer stock: is it a sell after starboard fires shots in its battle with management? Investor's Business Daily Wed, 23 Oct 2024 12:00:00 GMT
• pfizer backs out of everett manufacturing plant after $43b seagen deal MSN Tue, 22 Oct 2024 19:23:37 GMT
• starboard scolds pfizer over $20 billion value destruction BNN Bloomberg Tue, 22 Oct 2024 07:00:00 GMT
• is pfizer stock a sell as it wages battle with an activist investor? Investor's Business Daily Thu, 17 Oct 2024 12:00:00 GMT
• antibody-drug conjugate for cancer market (2024-2034):gilead sciences, roche, pfizer, takeda, seagen, innate pharma, ast – indiapo... IndiaPolitics.com Tue, 15 Oct 2024 03:07:37 GMT
• brentuximub vedoti market 2034 | key brands -seagen, takada IndiaPolitics.com Mon, 14 Oct 2024 07:19:20 GMT
• pfizer crashes 7% after issuing a disappointing outlook as seagen takeover looms MSN Fri, 11 Oct 2024 17:35:30 GMT
• is pfizer stock a sell as it wages battle with an activist investor? Investor's Business Daily Fri, 11 Oct 2024 12:01:00 GMT
• alpmy - astellas pharma unsp/adr latest stock news & market updates StockTitan Thu, 10 Oct 2024 21:44:16 GMT
• as a billionaire activist takes a stake, is now the time to buy pfizer stock? The Motley Fool Wed, 09 Oct 2024 07:00:00 GMT
• Immunome Appoints Roee Shahar as Executive Vice President, Commercial BioSpace Tue, 08 Oct 2024 07:00:00 GMT
• Pfizer Inc. (PFE) Acquires Seagen for $43 Billion, Strengthening Oncology Leadership Yahoo Finance Mon, 30 Sep 2024 07:00:00 GMT
• romania’s 'vast' offshore wind potential set out in new roadmap Recharge Mon, 30 Sep 2024 07:00:00 GMT
Seagen Inc(NASDAQ:SGEN) 
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADC...
Website: http://www.seattlegenetics.com
Founded: 1997
Full Time Employees: 1,605
Sector: Healthcare
Industry: Biotechnology